HTG Molecular Diagnostics is a leading provider of molecular-based solutions for gene expression profiling, miRNA and mRNA measurement, translational medicine and diagnostic applications. The Company’s qNPA™ molecular technology platform is well-suited for reliably detecting small, yet important, changes in gene expression levels in a variety of sample types. Privately-held HTG is based in Tucson, Arizona.

CEO: Tim Johnson Contact Info: 3430 E. Global Loop, Tucson, AZ 85706 Website: